
FDA relaxes oversight of AI-enabled devices and wearables
Key Points:
- The FDA announced plans to ease regulation of digital health products, continuing the Trump administration's push to deregulate artificial intelligence and encourage its broad adoption.
- FDA Commissioner Marty Makary emphasized the need for regulations to keep pace with rapid technological advancements, aiming to create a favorable environment for investors.
- The announcement was made during Makary's speech at the Consumer Electronics Show, highlighting the agency's commitment to aligning regulatory processes with "Silicon Valley speed."




:max_bytes(150000):strip_icc()/GettyImages-22400154171-19eb2573d96647f8894478942b5721be.jpg)





